nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Nephrosis lower nephron—Efavirenz—acquired immunodeficiency syndrome	0.0946	0.0946	CcSEcCtD
Capreomycin—Nephritis—Indinavir—acquired immunodeficiency syndrome	0.0307	0.0307	CcSEcCtD
Capreomycin—Renal tubular necrosis—Efavirenz—acquired immunodeficiency syndrome	0.0278	0.0278	CcSEcCtD
Capreomycin—Foetor hepaticus—Nevirapine—acquired immunodeficiency syndrome	0.0237	0.0237	CcSEcCtD
Capreomycin—Urine abnormality—Nelfinavir—acquired immunodeficiency syndrome	0.0235	0.0235	CcSEcCtD
Capreomycin—Foetor hepaticus—Stavudine—acquired immunodeficiency syndrome	0.0229	0.0229	CcSEcCtD
Capreomycin—Urine analysis abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.0222	0.0222	CcSEcCtD
Capreomycin—Foetor hepaticus—Zidovudine—acquired immunodeficiency syndrome	0.0199	0.0199	CcSEcCtD
Capreomycin—Liver disorder—Nevirapine—acquired immunodeficiency syndrome	0.0197	0.0197	CcSEcCtD
Capreomycin—Liver disorder—Stavudine—acquired immunodeficiency syndrome	0.0191	0.0191	CcSEcCtD
Capreomycin—Urine abnormality—Indinavir—acquired immunodeficiency syndrome	0.019	0.019	CcSEcCtD
Capreomycin—Urine analysis abnormal—Indinavir—acquired immunodeficiency syndrome	0.0179	0.0179	CcSEcCtD
Capreomycin—Liver disorder—Zidovudine—acquired immunodeficiency syndrome	0.0166	0.0166	CcSEcCtD
Capreomycin—Hepatocellular injury—Didanosine—acquired immunodeficiency syndrome	0.015	0.015	CcSEcCtD
Capreomycin—Hepatocellular injury—Nevirapine—acquired immunodeficiency syndrome	0.0135	0.0135	CcSEcCtD
Capreomycin—Hepatocellular injury—Stavudine—acquired immunodeficiency syndrome	0.013	0.013	CcSEcCtD
Capreomycin—Liver disorder—Saquinavir—acquired immunodeficiency syndrome	0.0124	0.0124	CcSEcCtD
Capreomycin—Abscess—Delavirdine—acquired immunodeficiency syndrome	0.012	0.012	CcSEcCtD
Capreomycin—Hearing impaired—Zidovudine—acquired immunodeficiency syndrome	0.0119	0.0119	CcSEcCtD
Capreomycin—Renal impairment—Didanosine—acquired immunodeficiency syndrome	0.0114	0.0114	CcSEcCtD
Capreomycin—Hepatocellular injury—Zidovudine—acquired immunodeficiency syndrome	0.0113	0.0113	CcSEcCtD
Capreomycin—Abscess—Saquinavir—acquired immunodeficiency syndrome	0.0107	0.0107	CcSEcCtD
Capreomycin—Hypocalcaemia—Delavirdine—acquired immunodeficiency syndrome	0.0104	0.0104	CcSEcCtD
Capreomycin—Hypocalcaemia—Saquinavir—acquired immunodeficiency syndrome	0.00923	0.00923	CcSEcCtD
Capreomycin—Hearing impaired—Ritonavir—acquired immunodeficiency syndrome	0.00922	0.00922	CcSEcCtD
Capreomycin—Deafness—Zidovudine—acquired immunodeficiency syndrome	0.00916	0.00916	CcSEcCtD
Capreomycin—Hearing impaired—Saquinavir—acquired immunodeficiency syndrome	0.00887	0.00887	CcSEcCtD
Capreomycin—Hepatocellular injury—Ritonavir—acquired immunodeficiency syndrome	0.00878	0.00878	CcSEcCtD
Capreomycin—Hearing impaired—Lamivudine—acquired immunodeficiency syndrome	0.00847	0.00847	CcSEcCtD
Capreomycin—Eosinophilia—Nevirapine—acquired immunodeficiency syndrome	0.00836	0.00836	CcSEcCtD
Capreomycin—Renal impairment—Indinavir—acquired immunodeficiency syndrome	0.00801	0.00801	CcSEcCtD
Capreomycin—Renal impairment—Efavirenz—acquired immunodeficiency syndrome	0.00757	0.00757	CcSEcCtD
Capreomycin—Renal failure—Nevirapine—acquired immunodeficiency syndrome	0.0074	0.0074	CcSEcCtD
Capreomycin—Deafness—Ritonavir—acquired immunodeficiency syndrome	0.00712	0.00712	CcSEcCtD
Capreomycin—Renal failure—Abacavir—acquired immunodeficiency syndrome	0.00704	0.00704	CcSEcCtD
Capreomycin—Deafness—Saquinavir—acquired immunodeficiency syndrome	0.00686	0.00686	CcSEcCtD
Capreomycin—Renal impairment—Ritonavir—acquired immunodeficiency syndrome	0.00669	0.00669	CcSEcCtD
Capreomycin—Hypokalaemia—Efavirenz—acquired immunodeficiency syndrome	0.00655	0.00655	CcSEcCtD
Capreomycin—Deafness—Lamivudine—acquired immunodeficiency syndrome	0.00654	0.00654	CcSEcCtD
Capreomycin—Renal impairment—Saquinavir—acquired immunodeficiency syndrome	0.00644	0.00644	CcSEcCtD
Capreomycin—Renal impairment—Lamivudine—acquired immunodeficiency syndrome	0.00615	0.00615	CcSEcCtD
Capreomycin—Eosinophilia—Delavirdine—acquired immunodeficiency syndrome	0.0059	0.0059	CcSEcCtD
Capreomycin—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.00585	0.00585	CcSEcCtD
Capreomycin—Renal failure—Indinavir—acquired immunodeficiency syndrome	0.00577	0.00577	CcSEcCtD
Capreomycin—Hypokalaemia—Saquinavir—acquired immunodeficiency syndrome	0.00558	0.00558	CcSEcCtD
Capreomycin—Renal failure—Efavirenz—acquired immunodeficiency syndrome	0.00545	0.00545	CcSEcCtD
Capreomycin—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.00523	0.00523	CcSEcCtD
Capreomycin—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.0051	0.0051	CcSEcCtD
Capreomycin—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.00508	0.00508	CcSEcCtD
Capreomycin—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.00503	0.00503	CcSEcCtD
Capreomycin—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.00501	0.00501	CcSEcCtD
Capreomycin—Renal failure—Ritonavir—acquired immunodeficiency syndrome	0.00483	0.00483	CcSEcCtD
Capreomycin—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.0047	0.0047	CcSEcCtD
Capreomycin—Renal failure—Saquinavir—acquired immunodeficiency syndrome	0.00465	0.00465	CcSEcCtD
Capreomycin—Tinnitus—Efavirenz—acquired immunodeficiency syndrome	0.00464	0.00464	CcSEcCtD
Capreomycin—Pain—Didanosine—acquired immunodeficiency syndrome	0.00456	0.00456	CcSEcCtD
Capreomycin—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00455	0.00455	CcSEcCtD
Capreomycin—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00454	0.00454	CcSEcCtD
Capreomycin—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00447	0.00447	CcSEcCtD
Capreomycin—Tinnitus—Delavirdine—acquired immunodeficiency syndrome	0.00444	0.00444	CcSEcCtD
Capreomycin—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00443	0.00443	CcSEcCtD
Capreomycin—Renal failure—Lamivudine—acquired immunodeficiency syndrome	0.00443	0.00443	CcSEcCtD
Capreomycin—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00442	0.00442	CcSEcCtD
Capreomycin—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00422	0.00422	CcSEcCtD
Capreomycin—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00412	0.00412	CcSEcCtD
Capreomycin—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.00411	0.00411	CcSEcCtD
Capreomycin—Pain—Nevirapine—acquired immunodeficiency syndrome	0.0041	0.0041	CcSEcCtD
Capreomycin—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00397	0.00397	CcSEcCtD
Capreomycin—Pain—Stavudine—acquired immunodeficiency syndrome	0.00396	0.00396	CcSEcCtD
Capreomycin—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.00396	0.00396	CcSEcCtD
Capreomycin—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00394	0.00394	CcSEcCtD
Capreomycin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00393	0.00393	CcSEcCtD
Capreomycin—Pain—Abacavir—acquired immunodeficiency syndrome	0.0039	0.0039	CcSEcCtD
Capreomycin—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.0039	0.0039	CcSEcCtD
Capreomycin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00381	0.00381	CcSEcCtD
Capreomycin—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00379	0.00379	CcSEcCtD
Capreomycin—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00373	0.00373	CcSEcCtD
Capreomycin—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00371	0.00371	CcSEcCtD
Capreomycin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Capreomycin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Capreomycin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Capreomycin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00368	0.00368	CcSEcCtD
Capreomycin—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00367	0.00367	CcSEcCtD
Capreomycin—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00367	0.00367	CcSEcCtD
Capreomycin—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00366	0.00366	CcSEcCtD
Capreomycin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00363	0.00363	CcSEcCtD
Capreomycin—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00361	0.00361	CcSEcCtD
Capreomycin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00354	0.00354	CcSEcCtD
Capreomycin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00347	0.00347	CcSEcCtD
Capreomycin—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Capreomycin—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00344	0.00344	CcSEcCtD
Capreomycin—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00343	0.00343	CcSEcCtD
Capreomycin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00342	0.00342	CcSEcCtD
Capreomycin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00341	0.00341	CcSEcCtD
Capreomycin—Rash—Didanosine—acquired immunodeficiency syndrome	0.00337	0.00337	CcSEcCtD
Capreomycin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00336	0.00336	CcSEcCtD
Capreomycin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00336	0.00336	CcSEcCtD
Capreomycin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00332	0.00332	CcSEcCtD
Capreomycin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00332	0.00332	CcSEcCtD
Capreomycin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00331	0.00331	CcSEcCtD
Capreomycin—Pain—Indinavir—acquired immunodeficiency syndrome	0.0032	0.0032	CcSEcCtD
Capreomycin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.0032	0.0032	CcSEcCtD
Capreomycin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00318	0.00318	CcSEcCtD
Capreomycin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00317	0.00317	CcSEcCtD
Capreomycin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00315	0.00315	CcSEcCtD
Capreomycin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00307	0.00307	CcSEcCtD
Capreomycin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00303	0.00303	CcSEcCtD
Capreomycin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00303	0.00303	CcSEcCtD
Capreomycin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00302	0.00302	CcSEcCtD
Capreomycin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Capreomycin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00296	0.00296	CcSEcCtD
Capreomycin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00295	0.00295	CcSEcCtD
Capreomycin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00293	0.00293	CcSEcCtD
Capreomycin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00293	0.00293	CcSEcCtD
Capreomycin—Rash—Stavudine—acquired immunodeficiency syndrome	0.00292	0.00292	CcSEcCtD
Capreomycin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00292	0.00292	CcSEcCtD
Capreomycin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.0029	0.0029	CcSEcCtD
Capreomycin—Rash—Abacavir—acquired immunodeficiency syndrome	0.00288	0.00288	CcSEcCtD
Capreomycin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00288	0.00288	CcSEcCtD
Capreomycin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Capreomycin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00281	0.00281	CcSEcCtD
Capreomycin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.0028	0.0028	CcSEcCtD
Capreomycin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00276	0.00276	CcSEcCtD
Capreomycin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00269	0.00269	CcSEcCtD
Capreomycin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00268	0.00268	CcSEcCtD
Capreomycin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00268	0.00268	CcSEcCtD
Capreomycin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00261	0.00261	CcSEcCtD
Capreomycin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00258	0.00258	CcSEcCtD
Capreomycin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Capreomycin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Capreomycin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Capreomycin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Capreomycin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00248	0.00248	CcSEcCtD
Capreomycin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00246	0.00246	CcSEcCtD
Capreomycin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Capreomycin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Capreomycin—Rash—Indinavir—acquired immunodeficiency syndrome	0.00236	0.00236	CcSEcCtD
Capreomycin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00236	0.00236	CcSEcCtD
Capreomycin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00231	0.00231	CcSEcCtD
Capreomycin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00228	0.00228	CcSEcCtD
Capreomycin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00227	0.00227	CcSEcCtD
Capreomycin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Capreomycin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Capreomycin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00222	0.00222	CcSEcCtD
Capreomycin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00214	0.00214	CcSEcCtD
Capreomycin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Capreomycin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00212	0.00212	CcSEcCtD
Capreomycin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Capreomycin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Capreomycin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Capreomycin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Capreomycin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00181	0.00181	CcSEcCtD
Capreomycin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00181	0.00181	CcSEcCtD
